Labcorp has launched a new first trimester preeclampsia screening test, making it the only laboratory in the United States to offer preeclampsia risk detection across all pregnancy trimesters, according to the company. The test, designed to be performed between 11 and 14 weeks of gestation, determines the risk of developing preeclampsia before 34 weeks of pregnancy. This innovation is significant for all…
Amplexd Therapeutics has secured $2 million in funding from an Asia-based family office specializing in life sciences. This investment supports the finalization of product development and the initiation of Phase 1/2 clinical trials for non-invasive treatments targeting Cervical Intraepithelial Neoplasia (CIN). “The funding marks a major milestone in our R&D efforts for our two therapies after extremely promising preclinical studies were completed.…
Acclinate, a company mobilizing diverse communities for improved healthcare access, has announced the successful closure of its $7 million Series A financing round. Led by Cencora Ventures, with participation from Labcorp and Latimer Ventures, this funding will support Acclinate’s efforts to expand its impact in the realm of clinical trial diversity and health equity. “This investment represents a pivotal moment for Acclinate…
In a recent study, Gameto revealed promising findings regarding their investigational in vitro maturation (IVM) solution, Fertilo. Led by CEO and co-founder Dr. Dina Radenkovic, the biotech company showcased the intricate cellular engineering and manufacturing processes behind Fertilo. The novel solution contains engineered ovarian support cells (OSCs), aimed at maturing eggs outside the body. “This study is the first to demonstrate the…
Solarea Bio, a US-based clinical-stage biotech company, is pioneering a new approach to bone health management with the beta launch of Bondia. The company is dedicated to leveraging microbial diversity to develop innovative solutions for managing inflammatory diseases. Through its consumer health brand, Journa, the company aims to improve human wellbeing with clinically tested and naturally formulated medical food products. Bondia, a…
Hera Biotech has shared interim findings from its ongoing clinical trial evaluating the MetriDx endometriosis diagnostic test. This trial, aimed at assessing the world’s first molecular, cell-based test for diagnosing and staging endometriosis without surgery, has reached the interim data analysis phase, shedding light on promising outcomes. Based on protocol data from the initial 38 participants enrolled in the 60-patient study, the…
Seed Health has launched CODA, a computational biology platform aimed at discovering and developing precision probiotics and microbiome-directed interventions. Powered by the Human Phenotype Project, the world’s most extensive multi-omics dataset, CODA focuses on advancing research in metabolic health, brain health, menopause, and longevity. CODA integrates over three million phenotypic data points from more than 13,000 individuals across 40,000 cumulative subject years.…
BoobyBiome, a UK-based startup headquartered in the Great Ormond Street Institute of Child Health, is on a mission to transform infant health for generations to come. Founded by three female entrepreneurs with expertise in microbiology, neuroscience, chemistry, and biophysics, BoobyBiome is advancing the field of infant feeding by harnessing the power of the breast milk microbiome. Since its inception in 2019, BoobyBiome…
